Amanjit Bal Selected Research

Amanjit Bal Research Topics

Disease

24	Neoplasms (Cancer) 09/2022 - 03/2005
17	Breast Neoplasms (Breast Cancer) 05/2022 - 09/2012
8	Carcinoma (Carcinomatosis) 07/2021 - 06/2013
6	Neoplasm Metastasis (Metastasis) 12/2021 - 02/2015
6	Infections 04/2021 - 09/2009
5	Lymphoma (Lymphomas) 01/2022 - 04/2008
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 05/2010
4	Lung Neoplasms (Lung Cancer) 09/2022 - 05/2016
4	Adenocarcinoma 01/2021 - 02/2003
4	Lymphatic Metastasis 01/2021 - 07/2008
4	Necrosis 03/2018 - 08/2014
3	Triple Negative Breast Neoplasms 01/2022 - 06/2021
3	Bronchiectasis 04/2021 - 01/2014
3	Poisoning 01/2021 - 04/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 02/2003
3	Tuberculosis (Tuberculoses) 01/2019 - 08/2014
3	Pleural Effusion (Pleural Effusions) 01/2019 - 03/2015
3	Sarcoidosis (Schaumann Disease) 10/2016 - 04/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2015 - 01/2009
2	Pulmonary Alveolar Proteinosis 01/2022 - 04/2012
2	Mucormycosis 01/2022 - 11/2014
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2021 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 07/2021 - 04/2020
2	Disease Progression 01/2021 - 08/2010
2	Vasculitis (Vasculitides) 01/2021 - 01/2014
2	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 12/2019
2	Glomerulonephritis 09/2018 - 01/2014
2	Immunoglobulin G4-Related Disease 07/2018 - 01/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 06/2009
2	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2017 - 01/2016
2	Pneumonia (Pneumonitis) 06/2017 - 11/2014
2	Chronic Renal Insufficiency 01/2017 - 03/2015
2	Diabetes Mellitus 01/2017 - 11/2014
2	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2016 - 10/2015
2	Phlebitis 01/2015 - 12/2013
2	Body Weight (Weight, Body) 10/2014 - 10/2011
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 09/2022
1	Insulin Resistance 07/2022
1	Gynecomastia 07/2022
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 03/2022
1	Hereditary Complement Deficiency Diseases 03/2022
1	Melena 02/2022
1	COVID-19 01/2022

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2012
8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 12/2017
7	Immunoglobulin G (IgG)IBA 04/2021 - 12/2013
7	AntigensIBA 04/2021 - 04/2008
6	Phenobarbital (Luminal)FDA Link 01/2022 - 10/2016
5	Hormones (Hormone)IBA 07/2022 - 07/2008
5	DichlorvosIBA 05/2012 - 04/2010
4	Anaplastic Lymphoma KinaseIBA 10/2021 - 01/2015
3	Androgen Receptors (Androgen Receptor)IBA 07/2022 - 01/2021
3	Estrogens (Estrogen)FDA Link 01/2020 - 07/2008
3	Keratins (Keratin)IBA 05/2018 - 01/2008
2	68Ga-pentixaforIBA 09/2022 - 01/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2022 - 10/2021
2	Progesterone Receptors (Progesterone Receptor)IBA 07/2022 - 07/2008
2	Tamoxifen FDA LinkGeneric 05/2022 - 03/2020
2	Estrogen ReceptorsIBA 05/2022 - 03/2020
2	Pharmaceutical PreparationsIBA 04/2022 - 11/2014
2	Immunoglobulins (Immunoglobulin)IBA 03/2022 - 12/2019
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2022 - 08/2018
2	CytokinesIBA 10/2021 - 12/2011
2	Immunoglobulin E (IgE)IBA 04/2021 - 01/2014
2	ParaffinIBA 02/2021 - 02/2007
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 01/2014
2	AgglutininsIBA 01/2021 - 01/2020
2	SialoglycoproteinsIBA 01/2021 - 01/2020
2	ParaquatIBA 01/2021 - 02/2015
2	Indicators and Reagents (Reagents)IBA 03/2020 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 05/2016
2	CollagenIBA 10/2019 - 01/2017
2	PlatinumIBA 01/2019 - 05/2010
2	Biological ProductsIBA 01/2019 - 10/2016
2	Mucin-1 (CA 15-3 Antigen)IBA 05/2018 - 07/2008
2	Tuberculin (PPD)IBA 10/2016 - 08/2014
2	AluminumIBA 12/2013 - 01/2009
2	VimentinIBA 06/2009 - 01/2008
1	CXC ChemokinesIBA 09/2022
1	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2022
1	Peptides (Polypeptides)IBA 07/2022
1	Steroid Receptors (Steroid Receptor)IBA 07/2022
1	Parathyroid Hormone-Related ProteinIBA 07/2022
1	Aromatase (CYP19)IBA 07/2022
1	Trastuzumab (Herceptin)FDA Link 04/2022
1	Complement System Proteins (Complement)IBA 03/2022
1	PAR-2 ReceptorIBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 01/2022
1	aspartic acid glycine arginineIBA 01/2022
1	liposomal amphotericin B FDA Link 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022

Therapy/Procedure

14	Therapeutics 01/2022 - 05/2010
9	Drug Therapy (Chemotherapy) 03/2022 - 05/2010
3	Neoadjuvant Therapy 01/2022 - 09/2015
3	Nephrectomy 01/2013 - 03/2005
2	Surgical Instruments (Clip) 01/2019 - 01/2016
2	Thoracoscopes 01/2017 - 04/2015
2	Radiotherapy 04/2013 - 02/2003
1	Blood Transfusion (Blood Transfusions) 02/2022
1	Mastectomy (Mammectomy) 01/2022